Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
44
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Surrozen Inc market cap is $542.49M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Surrozen Inc 52 week high is $37.83 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Surrozen Inc 52 week low is $12.79 as of November 22, 2026.
Surrozen Inc stock price today is $28.46.
Surrozen Inc stock price yesterday was $30.67.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Surrozen Inc's P/E ratio is -0.61.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Surrozen Inc P/B ratio is -1.0199.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Surrozen Inc 50-day moving average is $26.93.